Literature DB >> 30911805

Direct oral anticoagulants for venous thromboembolism prophylaxis in critically ill patients: where do we go from here?

Laurent Bertoletti1,2,3, Martin Murgier2,4, Henry T Stelfox5,6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30911805     DOI： 10.1007/s00134-019-05605-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.

Authors:  Hervé Decousus; Victor F Tapson; Jean-François Bergmann; Beng H Chong; James B Froehlich; Ajay K Kakkar; Geno J Merli; Manuel Monreal; Mashio Nakamura; Ricardo Pavanello; Mario Pini; Franco Piovella; Frederick A Spencer; Alex C Spyropoulos; Alexander G G Turpie; Rainer B Zotz; Gordon Fitzgerald; Frederick A Anderson
Journal:  Chest       Date:  2010-05-07       Impact factor: 9.410

2.  Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.

Authors:  Samuel Z Goldhaber; Alain Leizorovicz; Ajay K Kakkar; Sylvia K Haas; Geno Merli; Robert M Knabb; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2011-11-13       Impact factor: 91.245

Review 3.  Direct oral anticoagulants: Current indications and unmet needs in the treatment of venous thromboembolism.

Authors:  Laurent Bertoletti; Edouard Ollier; Cécile Duvillard; Xavier Delavenne; Marie-Noëlle Beyens; Elodie De Magalhaes; Florelle Bellet; Thierry Basset; Patrick Mismetti; Silvy Laporte
Journal:  Pharmacol Res       Date:  2016-06-24       Impact factor: 7.658

4.  Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.

Authors:  Gerald Chi; C Michael Gibson; Arzu Kalayci; Alexander T Cohen; Adrian F Hernandez; Russell D Hull; Farima Kahe; Mehrian Jafarizade; Sadaf Sharfaei; Yuyin Liu; Robert A Harrington; Samuel Z Goldhaber
Journal:  Intensive Care Med       Date:  2019-02-18       Impact factor: 17.440

5.  Effect of published scientific evidence on glycemic control in adult intensive care units.

Authors:  Daniel J Niven; Gordon D Rubenfeld; Andrew A Kramer; Henry T Stelfox
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

6.  Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

Authors:  Alexander T Cohen; Theodore E Spiro; Harry R Büller; Lloyd Haskell; Dayi Hu; Russell Hull; Alexandre Mebazaa; Geno Merli; Sebastian Schellong; Alex C Spyropoulos; Victor Tapson
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245

7.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.

Authors:  Holger J Schünemann; Mary Cushman; Allison E Burnett; Susan R Kahn; Jan Beyer-Westendorf; Frederick A Spencer; Suely M Rezende; Neil A Zakai; Kenneth A Bauer; Francesco Dentali; Jill Lansing; Sara Balduzzi; Andrea Darzi; Gian Paolo Morgano; Ignacio Neumann; Robby Nieuwlaat; Juan J Yepes-Nuñez; Yuan Zhang; Wojtek Wiercioch
Journal:  Blood Adv       Date:  2018-11-27

8.  A multicentre controlled pre-post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients.

Authors:  Henry T Stelfox; Rebecca Brundin-Mather; Andrea Soo; Jeanna Parsons Leigh; Daniel J Niven; Kirsten M Fiest; Christopher James Doig; Danny J Zuege; Barry Kushner; Fiona Clement; Sharon E Straus; Deborah J Cook; Sean M Bagshaw; Khara M Sauro
Journal:  Intensive Care Med       Date:  2019-02-01       Impact factor: 17.440

Review 9.  Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials.

Authors:  Waleed Alhazzani; Wendy Lim; Roman Z Jaeschke; Mohammad Hassan Murad; Jack Cade; Deborah J Cook
Journal:  Crit Care Med       Date:  2013-09       Impact factor: 7.598

Review 10.  Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis.

Authors:  Clémence Minet; Leila Potton; Agnès Bonadona; Rébecca Hamidfar-Roy; Claire Ara Somohano; Maxime Lugosi; Jean-Charles Cartier; Gilbert Ferretti; Carole Schwebel; Jean-François Timsit
Journal:  Crit Care       Date:  2015-08-18       Impact factor: 9.097
View more
  2 in total

1.  Venous thromboembolism and COVID-19.

Authors:  L Bertoletti; F Couturaud; D Montani; F Parent; O Sanchez
Journal:  Respir Med Res       Date:  2020-04-28

2.  Development and Validation of a Risk Assessment Model for Venous Thromboembolism in Patients With Invasive Mechanical Ventilation.

Authors:  Jiajia Lin; Yue Zhang; Weixian Lin; Ying Meng
Journal:  Cureus       Date:  2022-07-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.